Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A T van Oosterom

Showing results (161-170 of 196) with videos related to

Pageof 20
Sort By:
Anti-Cancer Drugs|March 24, 1998
Cisplatin-DNA adducts and protein-bound platinum in blood of testicular cancer patientsP Boffetta, A M Fichtinger-Schepman, E Weiderpass, et al.
Cancer Immunology, Immunotherapy : CII|October 1, 1993
Drug resistance in rat colon cancer cell lines is associated with minor changes in susceptibility to cytotoxic cellsW Van de Vrie, S A Van der Heyden, E E Gheuens, et al.
Seminars in Oncology|February 1, 1992
Replacement of cisplatin with carboplatin in combination chemotherapy against ovarian cancer: long-term treatment results of a study of the Gynaecological Cancer Cooperative Group of the EORTC and experience at The Netherlands Cancer InstituteW W ten Bokkel Huinink, O Dalesio, S Rodenhuis, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|April 8, 2000
Simultaneous determination of the peptide-mitomycin KW-2149 and its metabolites in plasma by high-performance liquid chromatographyZ D Zhang, G Guetens, G De Boeck, et al.
Journal of Chromatography. A|December 5, 2002
Hyphenated techniques in anticancer drug monitoring. I. Capillary gas chromatography-mass spectrometryG Guetens, G De Boeck, M Wood, et al.
Cancer Research|May 15, 1987
Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer Multiinstitutional Phase III StudyG Stoter, R Sylvester, D T Sleijfer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycinG Stoter, A Koopman, C P Vendrik, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Long-term follow-up of non-seminomatous testicular cancer patients with mature teratoma or carcinoma at postchemotherapy surgery. EORTC Genitourinary Tract Cancer Cooperative Group (EORTC GU Group)R L Jansen, R Sylvester, D T Sleyfer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1986
High-dose versus low-dose vinblastine in cisplatin-vinblastine-bleomycin combination chemotherapy of non-seminomatous testicular cancer: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative GroupG Stoter, D T Sleyfer, W W ten Bokkel Huinink, et al.
Seminars in Oncology|September 1, 1984
Mitoxantrone as first-line chemotherapy for advanced breast cancer: results of a European collaborative studyJ F Smyth, M A Cornbleet, R C Stuart-Harris, et al.
Pageof 20

Showing results (161-170 of 196) with videos related to

Sort By:
Pageof 20
Anti-Cancer Drugs|March 24, 1998
Cisplatin-DNA adducts and protein-bound platinum in blood of testicular cancer patientsP Boffetta, A M Fichtinger-Schepman, E Weiderpass, et al.
Cancer Immunology, Immunotherapy : CII|October 1, 1993
Drug resistance in rat colon cancer cell lines is associated with minor changes in susceptibility to cytotoxic cellsW Van de Vrie, S A Van der Heyden, E E Gheuens, et al.
Seminars in Oncology|February 1, 1992
Replacement of cisplatin with carboplatin in combination chemotherapy against ovarian cancer: long-term treatment results of a study of the Gynaecological Cancer Cooperative Group of the EORTC and experience at The Netherlands Cancer InstituteW W ten Bokkel Huinink, O Dalesio, S Rodenhuis, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|April 8, 2000
Simultaneous determination of the peptide-mitomycin KW-2149 and its metabolites in plasma by high-performance liquid chromatographyZ D Zhang, G Guetens, G De Boeck, et al.
Journal of Chromatography. A|December 5, 2002
Hyphenated techniques in anticancer drug monitoring. I. Capillary gas chromatography-mass spectrometryG Guetens, G De Boeck, M Wood, et al.
Cancer Research|May 15, 1987
Multivariate analysis of prognostic factors in patients with disseminated nonseminomatous testicular cancer: results from a European Organization for Research on Treatment of Cancer Multiinstitutional Phase III StudyG Stoter, R Sylvester, D T Sleijfer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycinG Stoter, A Koopman, C P Vendrik, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Long-term follow-up of non-seminomatous testicular cancer patients with mature teratoma or carcinoma at postchemotherapy surgery. EORTC Genitourinary Tract Cancer Cooperative Group (EORTC GU Group)R L Jansen, R Sylvester, D T Sleyfer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1986
High-dose versus low-dose vinblastine in cisplatin-vinblastine-bleomycin combination chemotherapy of non-seminomatous testicular cancer: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative GroupG Stoter, D T Sleyfer, W W ten Bokkel Huinink, et al.
Seminars in Oncology|September 1, 1984
Mitoxantrone as first-line chemotherapy for advanced breast cancer: results of a European collaborative studyJ F Smyth, M A Cornbleet, R C Stuart-Harris, et al.
Pageof 20